May 20th 2024
Both the World Health Organization and FDA have now recommended this particular set of viruses be left off influenza vaccines for 2024-2025 respiratory virus season. A new study points to further evidence of their extinction.
Evaluating the Effectiveness of High-Dose Trivalent vs Quadrivalent Flu Vaccine
November 2nd 2018Investigators have found the quadrivalent vaccination to be as effective as trivalent standard-dose, while the high-dose trivalent was found to be more effective than the trivalent standard-dose.
Read More
FDA Approves Baloxavir Marboxil to Treat Uncomplicated Influenza
October 24th 2018Today, the US Food and Drug Administration approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic for no more than 48 hours.
Read More